Synopsys Stock Performance
| SNPS Stock | USD 447.99 5.52 1.22% |
The entity has a beta of 1.15, which indicates a somewhat significant risk relative to the market. Synopsys returns are very sensitive to returns on the market. As the market goes up or down, Synopsys is expected to follow. At this point, Synopsys has a negative expected return of -0.14%. Please make sure to validate Synopsys' total risk alpha, accumulation distribution, as well as the relationship between the Accumulation Distribution and period momentum indicator , to decide if Synopsys performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Synopsys has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return (1.22) | Five Day Return 3.79 | Year To Date Return (7.20) | Ten Year Return 863.01 | All Time Return 5.6 K |
Last Split Factor 2:1 | Last Split Date 2003-09-24 |
1 | Synopsys Q1 Earnings Taking a Look at Key Metrics Versus Estimates | 02/26/2025 |
2 | Acquisition by Sassine Ghazi of tradable shares of Synopsys at 388.688 subject to Rule 16b-3 | 02/28/2025 |
3 | Hedge Fund and Insider Trading News Carl Icahn, Steve Cohen, Bill Ackman, Warren Buffett, Saba Capital, Jain Global, Bridgewater Associates, Grocery Outlet Hold... | 03/05/2025 |
4 | Baya Systems Revolutionizes AI Scale-Up and Scale-Out with NeuraScale Fabric | 03/06/2025 |
5 | Calculating The Fair Value Of Synopsys, Inc. | 03/07/2025 |
6 | Synopsys Inc Trading Down 3.53 percent on Mar 10 | 03/10/2025 |
7 | LDRA Launches Multicore and Worst-Case Execution Time Support for RISC-V-based Processors | 03/11/2025 |
8 | Intel Names Chip Industry Veteran Lip-Bu Tan as Its Next CEO | 03/12/2025 |
9 | Intel Names Chip Industry Veteran Tan as CEO | 03/13/2025 |
10 | PTC Welcomes Ex-Synopsys CFO Trac Pham to Board of Directors as Audit Committee Member | 03/14/2025 |
11 | LAU Holds its Centennial Gala in New York in Support of Student Scholarships and Healthcare | 03/17/2025 |
| Begin Period Cash Flow | 1.4 B |
Synopsys |
Synopsys Relative Risk vs. Return Landscape
If you would invest 49,335 in Synopsys on December 19, 2024 and sell it today you would lose (4,536) from holding Synopsys or give up 9.19% of portfolio value over 90 days. Synopsys is currently does not generate positive expected returns and assumes 2.203% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than Synopsys, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Synopsys Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Synopsys' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Synopsys, and traders can use it to determine the average amount a Synopsys' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0632
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SNPS |
Estimated Market Risk
| 2.2 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Synopsys is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Synopsys by adding Synopsys to a well-diversified portfolio.
Synopsys Fundamentals Growth
Synopsys Stock prices reflect investors' perceptions of the future prospects and financial health of Synopsys, and Synopsys fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Synopsys Stock performance.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0665 | ||||
| Profit Margin | 0.35 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 65.85 B | ||||
| Shares Outstanding | 154.62 M | ||||
| Price To Earning | 50.25 X | ||||
| Price To Book | 7.42 X | ||||
| Price To Sales | 11.55 X | ||||
| Revenue | 6.13 B | ||||
| Gross Profit | 4.94 B | ||||
| EBITDA | 1.36 B | ||||
| Net Income | 2.24 B | ||||
| Cash And Equivalents | 1.53 B | ||||
| Cash Per Share | 10.01 X | ||||
| Total Debt | 684.46 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 1.14 X | ||||
| Book Value Per Share | 60.18 X | ||||
| Cash Flow From Operations | 1.41 B | ||||
| Earnings Per Share | 8.30 X | ||||
| Market Capitalization | 70.12 B | ||||
| Total Asset | 13.07 B | ||||
| Retained Earnings | 8.98 B | ||||
| Working Capital | 3.82 B | ||||
| Current Asset | 1.72 B | ||||
| Current Liabilities | 1.71 B | ||||
About Synopsys Performance
Assessing Synopsys' fundamental ratios provides investors with valuable insights into Synopsys' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Synopsys is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 95.45 | 100.23 | |
| Return On Tangible Assets | 0.22 | 0.23 | |
| Return On Capital Employed | 0.15 | 0.14 | |
| Return On Assets | 0.20 | 0.21 | |
| Return On Equity | 0.29 | 0.30 |
Things to note about Synopsys performance evaluation
Checking the ongoing alerts about Synopsys for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Synopsys help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Synopsys generated a negative expected return over the last 90 days | |
| Synopsys is unlikely to experience financial distress in the next 2 years | |
| Synopsys has a strong financial position based on the latest SEC filings | |
| Over 91.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: LAU Holds its Centennial Gala in New York in Support of Student Scholarships and Healthcare |
- Analyzing Synopsys' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Synopsys' stock is overvalued or undervalued compared to its peers.
- Examining Synopsys' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Synopsys' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Synopsys' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Synopsys' stock. These opinions can provide insight into Synopsys' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Synopsys Stock Analysis
When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.